UK: Stanley Capital Partners acquires Drug Safety Solutions from Astorg and Nordic Capital-backed Clario

Stanley Capital Partners (SCP), the UK-based European and US-focused mid-market private equity firm, has acquired pharmacovigilance (PV) consultancy Drug Safety and Pharmacovigilance Services Solutions (DSS), from US-based Clario. Clario, a firm delivering endpoint technology solutions for clinical trials, was backed by Astorg, which took a position in 2020, and Nordic Capital. The financial terms of…

You must be a HMI Subscriber to view this content.

Subscribe Now »